Durata Therapeutics Cash Flow - Annual (NASDAQ:DRTX)

Add to My Stocks
$24.16 $0.41 (1.73%) DRTX stock closing price Nov 17, 2014 (Closing)

The financial analysis of DRTX requires an investor to check the cash flows for Durata Therapeutics. The profit-loss statement shows Durata Therapeutics profits, the balance sheet shows Durata Therapeutics debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Durata Therapeutics saw a cash impact of $54.15M from the issuance of DRTX shares. The cash flow statement helps in the Durata Therapeutics stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Durata Therapeutics saw a outflow of $-10.62M from investing activities for 2013.

View details of Durata Therapeutics cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec2013201220112010
Net Income Cash Flow
-62.14M-62.53M-33.03M-11.01M
Depreciation Depletion Amortization Cash-Flow----
Net Increase (Decrease) in Assets Liabilities-4.36M2.01M6.28M-
Cash From (used in) Discontinued Operations----
Other Adjustments Net5.43M2.5M-0.6M3.75M
Net Cash from (used by) Operating Activities
-60.81M-58.01M-27.35M-6.51M
Increase (Decrease) in Prop Plant And Equipment-0.44M-0.71M--
Acquisition Disposition of Subsidiaires----
Increase (Decrease) in Investments-9.88M-13.09M--
Other Cash Inflow (Outflow) from Investment Activities-0.29M-0.85M--0.04M
Net Cash from (used by) Investment Activities
-10.62M-14.66M--0.04M
Issuance (Purchase) of Equity Shares54.15M96.05M36M5.19M
Issuance (Repayment) of Debt Securities23.3M---
Increase (Decrease) in Bank & Other Borrowings----
Payment of Dividends & Other Cash Distributions----
Other Cash from (used by) Financing Activities-1.42M-2.61M--
Net Cash from (used by) Financing Activities
76.03M93.44M36.57M5.19M
Effect of Exchange Rate Changes on Cash----
Net Change in Cash & Cash Equivalents
4.59M20.77M9.22M-1.36M
Cash & Equivalents at Beginning of Year32.25M11.48M2.26M3.62M
Cash & Equivalents at Year End36.85M32.25M11.48M2.26M
All figures in USD. M: Millions of USD, B: Billions of USD.

Durata Therapeutics stock comparison chart provides an easy way to compare the stock price with peers along with details of Durata Therapeutics stock price history.
The statement of cash flows can be categorized into three main sections:

  • Durata Therapeutics had a Net Change in Cash and Cash Equivalents of $4.59M for the latest year 2013. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Durata Therapeutics stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Durata Therapeutics reported a negative operating cash flow of $-60.81M for 2013 and has seen a decrease from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-10.62M for DRTX in last 2013 report.
  • Cash flow from financing activities shows the flow of cash between Durata Therapeutics and its owners and creditors and was $76.03M for 2013. Financing activities allow a company to raise capital, and repay bondholders.